Skip to main content

Share India Securities Script included in the BSE Group 1

The script is one of the only four SME stocks, out of 209, to be included in this group.

Mumbai, November 7, 2017.  The script of Share India Securities Ltd, a leading knowledge and technology driven stock broker, has been included in the BSE Group -1 securities by Bombay Stock Exchange as per SEBI guidelines.  The script will now be able to avail margin funding facility at eligible broker terminals.

Share India Securities Script (BSE code 540725), which was listed on BSE SME platform on 5th of October 2017, has touched an all-time high of Rs 64.80 as against the IPO price of Rs 41.

“Margin is essentially an additional fund that you take to get more leverage in your investments. Share trading on margin allows you to purchase a greater number of securities than you would have been able to purchase with cash only, thereby giving you more exposure to the market and offering the possibility of greater returns.  We are happy that Share India Securities Ltd.'s script is part of BSE Group 1 Securities now. Share India script is one of the only four SME stocks, out of 209, to be included in the Group - 1” said Mr Abhinav Gupta, Vice President, Share India Securities Ltd.


About Share India Securities Ltd

Share India Securities Ltd, engaged in the business of equity broking, investing and trading activities for the last 24 years, became 200th SME Company to get listed on BSE SME Platform on 5th October 2017. The company in addition to providing the services as a Depository Participant, Research Analyst, Mutual Fund Advisor/Distributor, has also filed an application with Securities and Exchange Board of India for the registration of Company as a Portfolio Manager.
The Company has received many Awards and Recognitions some of them are, an award for appreciation for our contribution in the 1 crores Demat accounts opened by CDSL. Company has been accredited with certificate for being among the top performing members for the year 2015-16 in equity and equity derivatives segment of the National Stock Exchange of India Limited. Company has been accredited with certificate for being among the top performing members for the year 2015-16 in Currency derivative segment of the National Stock Exchange of India Limited.
For more information, please contact: Mr. Aryan Prem Rana, AARYANA MATASCO 
Email ID: info@aaryanamatasco.com 
www.aaryanamatasco.com

Comments

Popular posts from this blog

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

  Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars.  Adulteration with cheaper ...

CARE Ratings shares list at 25% premium on NSE

Credit Analysis and Research Limited (  CARE ) has listed at Rs 940, a 25% premium against its issue price of Rs 750 per share on the National Stock Exchange (NSE). The stock hit a high of Rs 955 and low of Rs 930 so far. A combined 1.41 million shares have changed hands on the counter in opening deals on the NSE and BSE. CARE, the second-largest credit rating agency in India, has raised Rs 540 crore by issuing 7.2 million shares through initial public offer (IPO). The company has fixed the issue price at higher price band at Rs 700-750 per share. The IPO attracted bids for 245.56 million shares against 7.2 million shares on offer, translating to 34.11 times subscription, according to information available in basis of allotment.   The category reserved for qualified institutional buyers (QIBs) was subscribed 43 times, while non-institutional investor’s portion received 110 times subscription. Shares reserved for retail investors got subscribed 6.11 tim...

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025.  Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...